0 items | $0.00

Complement Pathway Mouse


AGE products

Quick order

    Product added to cart.

    New products

    • Fecal Calprotectin, Human, Rapid ELISA kit

      Fecal Calprotectin, Human, Rapid ELISA kit

      The fecal Calprotectin ELISA kit is to be used for the in vitro quantitative determination of human calprotectin in feces in 1-step with a working time of 1.5 hours.
    • RNase 7, Human, ELISA kit

      RNase 7, Human, ELISA kit

      RNase 7 is an protein secreted by a variety of epithelial tissues and is a member of the RNase A superfamily. This family shares sequence and structural similarities such as conserved cysteine residues as well as conserved histidines and a lysine in the active center catalysing the ribonuclease activity.
    Want to stay informed about our products? Sign up for our newsletter:
    About Hycult Biotech


    About Hycult Biotech

    Since 1994, Hycult Biotech designs, develops, produces and markets antibodies, antibody based products and more specifically immunoassays for innate immunity and directly related fields, with an emphasis on complement, neutrophil proteins, TLR, scavenger receptors and acute phase proteins.

    Furthermore, we have a strong interest in progressing research in the area of inflammation and cell damage caused by pathogens or oxidation factors.

    "Hycult Biotech’s mission and strategy is to advance insight in innate immunity related diseases, for the benefit of individuals and their quality of life."

    As a leader within focused fields of immunology and cell biology, we develop products for the life sciences and in accordance with our mission it is our ambition to facilitate the transition of these products from research use into diagnostic testing.

    Many of our reagents are developed in close cooperation with scientists worldwide. Hycult Biotech has built a strong network with over 40 close scientific collaborations with leading international research institutes.

    We contribute to numerous projects and as a result, can continuously offer early access to... Read more »